Arkin Holdings

Type

Venture Capital

Status

Active

Location

Herzliya, Israel

Total investments

28

Average round size

38M

Portfolio companies

23

Rounds per year

2.00

Lead investments

4

Follow on index

0.18

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyFinancial ServicesFinTechHealth CareMedical DeviceMedicalLife ScienceTherapeuticsLendingClinical Trials

Summary

Arkin Holdings is the famous Corporate Investor, which was founded in 2010. The main department of described Corporate Investor is located in the Herzliya. The company was established in Asia in Israel.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Arkin Holdings, startups are often financed by Accelmed, Office of the Chief Scientist of Israel - OCS. The meaningful sponsors for the fund in investment in the same round are Pontifax, Primera Capital, Pfizer. In the next rounds fund is usually obtained by Jerusalem Global Ventures.

Among the most popular portfolio startups of the fund, we may highlight Quiet Therapeutics, Metabomed, cCAM Biotherapeutics. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Developer Platform. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2015. The important activity for fund was in 2016. Opposing the other organizations, this Arkin Holdings works on 9 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 60 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtechHealthcare

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
28
Lead investments
4
Exits
1
Rounds per year
2.00
Follow on index
0.18
Investments by industry
  • Health Care (12)
  • Biotechnology (10)
  • Medical (5)
  • Therapeutics (4)
  • Clinical Trials (3)
  • Show 39 more
Investments by region
  • United States (13)
  • Switzerland (1)
  • Israel (14)
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
74M
Group Appearance index
0.96
Avg. company exit year
6

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Amberlo 11 Jan 2021 Software, SaaS, Legal Seed 1M Kaunas County, Kaunas, Lithuania
Eleos Health 05 Apr 2022 Health Care Early Stage Venture 20M United States, Massachusetts, Cambridge
Honeycomb Insurance 07 May 2024 Insurance, Commercial Insurance Early Stage Venture 36M United States, California, San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.